Soon after infection, HIV-1 establishes a life-long presence by forming viral reservoirs in the body—cells that are infected with HIV but not actively producing new viruses. Antiretroviral therapy (ART) reduces HIV levels ...
Jan 10, 2023
0
32
Antiviral drugs almost completely reduce the risk of mothers passing on HIV infection to their children, even in a low-income country with a high HIV incidence such as Tanzania, according to a new study in The Lancet HIV ...
Dec 7, 2022
0
505
Though antiretroviral therapy has made HIV a manageable disease, people living with HIV often suffer from chronic inflammation. This can put them at an increased risk of developing comorbidities such as cardiovascular disease ...
Nov 22, 2022
0
78
An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health ...
Nov 14, 2022
0
45
The type of virus used as a model to study the efficacy of non-neutralizing antibodies against the virus responsible for AIDS has a crucial role to play, according to a new study led by Andrés Finzi, Université de Montréal ...
Nov 8, 2022
0
81
A phase I/IIa clinical trial that the University of Oxford collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was ...
Nov 4, 2022
0
33
A new method could make it possible to identify the most dangerous parts of the HIV virus, so they can be singled out for attack.
Oct 20, 2022
0
35
For around 40 years, scientists all over the world have been unsuccessfully trying to find a cure for HIV, but now a team of researchers from Aarhus University and Aarhus University Hospital have apparently found an important ...
Oct 17, 2022
0
52
People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 "breakthrough" infection after vaccination, according to a study led by researchers at the Johns Hopkins Bloomberg School ...
Oct 13, 2022
0
46
Scientists at Scripps Research, IAVI, the Ragon Institute and Moderna, Inc., have come together to make critical advances in developing an effective vaccine against human immunodeficiency virus (HIV).
Oct 3, 2022
0
56
